We have observed that some business executive of professional website are copying news from this website and start discussion on professional networking sites. Also, during discussion they do not acknowledge "IP Pharm doc" and instead show news item authored by their website.
I humbly request those executives to refrain from using "IP Pharm Doc" news for professional/commercial interest.
I humbly request those executives to refrain from using "IP Pharm Doc" news for professional/commercial interest.
No comments:
Post a Comment